Skip to main content

Advertisement

Table 1 Clinical and molecular characteristics of the non-glial CNS tumors patients

From: Is the presence of HCMV components in CNS tumors a glioma-specific phenomenon?

Histology n Sex Age (Years) Extent of resection IE1–72 pp65 Nest-PCR
M/F Mean ± SD Total removal (%) Subtotal removal (%) Positive of No. (%) Positive of No. (%) Positive of No. (%)
meningoma 65 24/41 48.76 ± 12.69 60 (92.3%) 5 (7.7%) 2 (3.1%) 3 (4.6%) 2 (3.1%)
 benign 57 18/39 48.14 ± 12.84 54 (94.7%) 3 (5.3%) 2 (3.5%) 3 (5.3%) 2 (3.5%)
 atypical/malignant 8 6/2 53.25 ± 11.34 6 (75.0%) 2 (25.0%) 0 0 0
pituitary adenoma 45 11/34 41.27 ± 10.44 33 (73.3%) 12 (26.7%) 0 0 0
 GH 15 3/12 42.13 ± 8.29 11 (73.3%) 4 (26.7%) 0 0 0
 PRL 19 2/17 42.11 ± 11.36 14 (73.7%) 5 (26.3%) 0 0 0
 ACTH 11 6/5 38.64 ± 11.85 8 (72.7%) 3 (27.3%) 0 0 0
cavernous hemangioma 20 7/13 47.05 ± 11.09 19 (95%) 1 (5%) 0 0 0
metastatic carcinoma 30 18/12 56.40 ± 12.27 28 (93.3%) 2 (6.7%) 2 (6.7%) 0 2 (6.7%)